Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2015 | 1 |
2016 | 2 |
2019 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Molecular biology in head and neck cancer.
Clin Transl Oncol. 2006 Nov;8(11):776-9. doi: 10.1007/s12094-006-0131-8.
Clin Transl Oncol. 2006.
PMID: 17134964
Review.
Targeted Therapy in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (LA-R/M HNSCC).
Echarri MJ, Lopez-Martin A, Hitt R.
Echarri MJ, et al.
Cancers (Basel). 2016 Feb 26;8(3):27. doi: 10.3390/cancers8030027.
Cancers (Basel). 2016.
PMID: 26927178
Free PMC article.
Review.
Item in Clipboard
The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Ramón Y Cajal T, Hernández-Agudo E, Heredia Soto V, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ.
Gayarre J, et al. Among authors: echarri mj.
J Gynecol Oncol. 2016 Jan;27(1):e7. doi: 10.3802/jgo.2016.27.e7. Epub 2015 Nov 27.
J Gynecol Oncol. 2016.
PMID: 26463438
Free PMC article.
Item in Clipboard
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).
Bachelot T, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Bondarenko I, Paluch-Shimon S, Wardley A, Merot JL, du Toit Y, Easton V, Lindegger N, Miles D; PERUSE investigators.
Bachelot T, et al.
Ann Oncol. 2019 May 1;30(5):766-773. doi: 10.1093/annonc/mdz061.
Ann Oncol. 2019.
PMID: 30796821
Free article.
Clinical Trial.
Item in Clipboard
A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer.
Ciruelos E, Apellániz-Ruiz M, Cantos B, Martinez-Jáñez N, Bueno-Muiño C, Echarri MJ, Enrech S, Guerra JA, Manso L, Pascual T, Dominguez C, Gonzalo JF, Sanz JL, Rodriguez-Antona C, Sepúlveda JM.
Ciruelos E, et al. Among authors: echarri mj.
Oncologist. 2019 Nov;24(11):e1024-e1033. doi: 10.1634/theoncologist.2017-0664. Epub 2019 Apr 25.
Oncologist. 2019.
PMID: 31023863
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite